EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis

Michael Ioannou iD, Örjan Falk, Joss Gustavsson, Johan Nilsson, Petteri Sjögren, Steinn Steingrimsson, Therese Svanberg, Zoltán Szabó, Susanna M Wallerstedt

Acta Neuropsychiatrica · 2026 · 38

DOI: 10.1017/neu.2026.10074 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Acta Neuropsychiatrica, online erschienen am 14.04.2026. Verfasst von Michael Ioannou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience and Physiology, https://ror.org/01tm6cn81University of Gothenburg Sahlgrenska Academy, Sweden. Hauptthemen laut MEDLINE: Clomipramine, Obsessive-Compulsive Disorder, Antidepressive Agents, Tricyclic, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In severe cases of depression and obsessive-compulsive disorder (OCD), clomipramine is sometimes administered parenterally. This systematic review aimed to investigate whether parenteral clomipramine is superior to oral clomipramine or other treatments, primarily in terms of reducing depressive/OCD symptoms within two weeks (CRD420250654029). Medline, Embase, the Cochrane Library, and PsycInfo were searched for relevant publications. Randomized controlled trials (RCTs) without a high risk of bias formed the primary basis for the conclusions. Meta-analyses were performed when applicable. Certainty of evidence was assessed according to GRADE. The literature search identified 4973 unique publications, whereof 14 RCTs contributed data regarding the question at issue in this systematic review. The evidence synthesis revealed that parenteral clomipramine may not be superior to oral administration in terms of reducing depressive symptoms within two weeks, but a clinically relevant effect cannot be excluded (low certainty of evidence; five RCTs including 70 patients; mean difference of change in Hamilton depression rating scale scores (meta-analysis based on three RCTs): −1.27 (95% confidence interval: −3.09 to 0.54; 2, I2 = 22%). Regarding patients with OCD, no conclusion could be drawn (very low certainty of evidence; two RCTs including 47 patients; meta-analysis not conducted due to heterogeneity). Regarding comparisons with other treatments, the available RCT (depression) did not allow for conclusions, or no RCTs (OCD) were available. Current evidence indicates that parenteral administration of clomipramine may not be favourable compared to oral administration, and RCTs with relevant comparisons such as electroconvulsive therapy and ketamine are lacking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClomipramineObsessive-Compulsive DisorderAntidepressive Agents, TricyclicDepressionSelective Serotonin Reuptake InhibitorsHumansAdministration, OralRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

clomipraminedepressionefficacyobsessive-compulsive disorderparenteral

Substanzen

ClomipramineAntidepressive Agents, TricyclicSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Institute of Neuroscience and Physiology, https://ror.org/01tm6cn81University of Gothenburg Sahlgrenska Academy, Sweden.
  • Psykiatri Affektiva, https://ror.org/04vgqjj36Sahlgrenska University Hospital, Sweden.
  • Medical Library, Sahlgrenska University Hospital, Sweden.
  • Department of Clinical Pharmacology, Sahlgrenska University Hospital, Sweden.
  • Center for Health Technology Assessment, Sahlgrenska University Hospital, Sweden.
  • Department of Pharmacology, University of Gothenburg Sahlgrenska Academy, Sweden.

ORCID-Profile: Michael Ioannou

Zitieren

APA

Ioannou, M., Falk, Ö., Gustavsson, J., Nilsson, J., Sjögren, P., Steingrimsson, S., Svanberg, T., Szabó, Z., & Wallerstedt, S. M. (2026). Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis. Acta Neuropsychiatrica, 38. https://doi.org/10.1017/neu.2026.10074

Vancouver

Ioannou M, Falk Ö, Gustavsson J, Nilsson J, Sjögren P, Steingrimsson S, et al. Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis. Acta Neuropsychiatrica. 2026;38. doi:10.1017/neu.2026.10074

BibTeX
@article{Ioannou2026,
  author = {Ioannou, Michael and Falk, Örjan and Gustavsson, Joss and Nilsson, Johan and Sjögren, Petteri and Steingrimsson, Steinn and Svanberg, Therese and Szabó, Zoltán and Wallerstedt, Susanna M},
  title = {Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis},
  journal = {Acta Neuropsychiatrica},
  year = {2026},
  volume = {38},
  doi = {10.1017/neu.2026.10074}
}
Kostenlos starten →